Accreditation/Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AstraZeneca, and Foundation Medicine, Inc.

Community Practice Connections™: Medical Crossfire®: How to Use Liquid Biopsies in Oncology Care

Release Date: August 30, 2019
Expiration Date: August 30, 2020
Media: Internet - based

Activity Overview

Community Practice Connections™: Medical Crossfire®: How to Use Liquid Biopsies in Oncology Care provides concise summaries and expert commentary on key clinical studies integrating liquid-based testing in patients with solid tumors. This activity includes interactive clinical vignettes and questions related to current and future applications of liquid biopsies, followed by short video interviews with leading experts in the management of patients with cancer. The video interviews address decision points in the clinical vignettes, as well as questions related to the rapidly developing field of liquid biopsies in oncology.

Benefits of Participating

  • Improve your knowledge of how liquid biopsies may improve the molecular characterization of patients with lung cancer
  • Learn about the emergence of plasma-based molecular testing in patients with breast cancer
  • Hear expert opinion on the potential of liquid biopsies in risk stratification of patients with colon cancer

Acknowledgement of Commercial Support

This activity is supported by educational grants from AstraZeneca, and Foundation Medicine, Inc.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Video” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Target Audience

This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists interested in liquid biopsies in the treatment of cancer. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with cancer are also invited to participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Evaluate the key differences between liquid biopsy and conventional tissue biopsy
  • Discuss the capabilities of currently available liquid biopsy technologies
  • Analyze the utility of liquid biopsies for different cancers, including non-small cell lung cancer, breast cancer, and GI cancers
  • Describe available clinical evidence on specific testing modalities that may help to individualize treatment protocols for patients with cancer

Faculty, Staff, and Planners’ Disclosures


Benjamin P. Levy
Benjamin P. Levy, MD
Associate Professor, Johns Hopkins School of Medicine
Clinical Director, Medical Oncology
Johns Hopkins Sidney Kimmel Cancer Center
Sibley Memorial Hospital
Washington, DC

Disclosures: Consultant: AstraZeneca, Celgene, Eli Lilly, Genentech, Merck, Takeda.

Charu Aggarwal
Charu Aggarwal, MD, MPH
Leslye Heisler Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Abramson Cancer Center
Philadelphia, PA

Disclosures: Grant/Research Support: AstraZeneca, Incyte, Merck; Consultant: AstraZeneca, Bristol-Myers Squibb, Celgene, Roche.

Massimo Cristofanilli
Massimo Cristofanilli, MD, FACP
Professor of Medicine
Associate Director, Translational Research and Precision Medicine
Director, OncoSET Precision Medicine Program
Department of Medicine-Hematology and Oncology
Robert H. Lurie Comprehensive Cancer Center
Feinberg School of Medicine
Chicago, IL

Disclosures: Consultant: CytoDyn, Merus, Novartis, Pfizer; Honoraria: Pfizer.

David R. Gandara
David R. Gandara, MD
Professor of Medicine
Division of Hematology/Oncology
Director of Thoracic Oncology Program
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Sacramento, CA

Disclosures: Grant/Research Support: Bristol-Myers Squibb, Genentech/ Roche, Novartis, Merck; Consultant: AstraZeneca, Celgene, CellMax, FujiFilm, Genentech/Roche, Guardant Health, Inivata, IO Biotech, Lilly, Liquid Genomics, Merck, Samsung Bioepis, Pfizer.

Jeanne Tie
Jeanne Tie, MD, FRACP, MBChB
Medical Oncologist
Peter MacCallum Cancer Centre & Western Health
Lower GI Clinical and Trials Lead, Peter MacCallum Cancer Centre
Senior Research Fellow, Walter and Eliza Hall Institute of Medical Research
Associate Professor of Medicine, University of Melbourne
Melbourne, Australia

Disclosures: Consultant: Steering Committee: MedImmune/AstraZeneca.

The staff of Physicians' Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines relevant financial relationships as financial relationships in any amount occurring within the past 12 months that create a conflict of interest (COI).

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of PER® or the companies that provided commercial support for this program.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By